Advisory Research Inc Tandem Diabetes Care Inc Transaction History

Advisory Research Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$53.13 - $71.19 $826,490 - $1.11 Million	-15,556 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$57.11 - $73.3 $29,297 - $37,602	-513 Reduced 3.19%	15,556 $917,000
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $874,314 - $1.15 Million	16,069 New	16,069 $1.04 Million

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.